Quest Diagnostics DGX
NYSE DGX
$247.35 +0.27 (+0.11%)
As of: Sep 17, 2026 · 3:59 PM EDT

Quest Diagnostics (DGX) Revenue Growth (3y) (2012 - 2026)

Analysis

Quest Diagnostics (DGX) Revenue Growth (3y) (2012 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue Growth (3y) (Qtr)
1 Natera 49.39 Bn 48.29 Bn 486.15 Mn 42.27%
2 Quest Diagnostics 27.49 Bn 26.86 Bn 1.03 Bn 9.18%
3 Labcorp Holdings 26.51 Bn 26.37 Bn 1.11 Bn 7.14%
4 Guardant Health 23.17 Bn 22.12 Bn 219.03 Mn 34.67%
5 Tempus AI 12.59 Bn 11.77 Bn 274.25 Mn 42.42%
6 Caris Life Sciences 8.01 Bn 7.22 Bn 182.38 Mn -
7 Sotera Health 5.53 Bn 5.17 Bn 177.96 Mn 7.98%
8 BillionToOne 4.80 Bn 4.25 Bn 77.11 Mn -
9 Adaptive Biotechnologies 4.40 Bn 4.05 Bn 51.39 Mn 13.51%
10 iRhythm Holdings 3.68 Bn 3.08 Bn 163.21 Mn 21.78%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 9.18%
Mar 31, 2026 7.49%
Dec 31, 2025 6.35%
Sep 30, 2025 4.24%
Jun 30, 2025 4.02%
Mar 31, 2025 0.52%
Dec 31, 2024 -1.52%
Sep 30, 2024 -3.56%
Jun 30, 2024 -2.04%
Mar 31, 2024 -4.54%
Dec 31, 2023 -8.66%
Sep 30, 2023 -6.26%
Jun 30, 2023 8.57%
Mar 31, 2023 8.56%
Dec 31, 2022 6.60%
Sep 30, 2022 8.32%
Jun 30, 2022 7.89%
Mar 31, 2022 11.35%
Dec 31, 2021 14.27%
Sep 30, 2021 13.66%